FDA Approves Zevaskyn for Rare, Genetic Skin Disorder
Zevaskyn is the first and only autologous cell-based gene therapy for recessive dystrophic epidermolysis bullosa
CDC Provides Update on Measles Outbreak in the United States
Outbreak mainly affected members of communities with low measles vaccination coverage in New Mexico, Oklahoma, and Texas
Early Combination of Lipid-Lowering Therapy Beneficial After Myocardial Infarction
In a recent study, one-year MACE incidences were 1.79, 2.58, and 4.03 per 100 patient-years for early, late, and no ezetimibe added to statins
Efanesoctocog Alfa Not Cost-Effective for Prophylaxis in Hemophilia A
Efanesoctocog alfa needs to be priced at <53 and <59 percent of current price for conventional and distributional cost-effectiveness
United States Seeing Uptick in Whooping Cough Cases
Number of cases this year has reached 8,485, twice as many as this time last year
Common Medications Tied to Older Age at Onset of Parkinson Disease
Almost 10-year delay seen for patients who were started on adrenergic blockers before onset of PD symptoms
Novavax COVID Vaccine Moves Closer to Full FDA Approval
HHS Announces Plans to Pay Moderna $176 Million for mRNA Flu Vaccine
Government hopes to be prepared for possible bird flu pandemic or outbreak of other flu variations
Brensocatib Leads to Lower Rate of Pulmonary Exacerbations in Bronchiectasis
Annualized rate of pulmonary exacerbations lower in 10-mg and 25-mg brensocatib groups versus placebo
Single-Dose Baloxavir Treatment Can Reduce Influenza Transmission
Transmission of laboratory-confirmed influenza significantly lower with baloxavir versus placebo by day 5
